Newbridge Financial Services Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Sell |
91
-124
| -58% | -$15.7K | ﹤0.01% | 850 |
|
|
2025
Q1 | $27.5K | Sell |
215
-34
| -14% | -$4.35K | 0.01% | 490 |
|
|
2024
Q4 | $32.9K | Buy |
+249
| New | +$32.9K | 0.01% | 507 |
|
|
2024
Q3 | – | Sell |
-263
| Closed | -$36.2K | – | 854 |
|
|
2024
Q2 | $36.2K | Sell |
263
-191
| -42% | -$26.3K | 0.01% | 444 |
|
|
2024
Q1 | $62.3K | Buy |
454
+143
| +46% | +$19.6K | 0.03% | 359 |
|
|
2023
Q4 | $42.3K | Sell |
311
-77
| -20% | -$10.5K | 0.02% | 431 |
|
|
2023
Q3 | $47.4K | Hold |
388
| – | – | 0.02% | 423 |
|
|
2023
Q2 | $49.3K | Buy |
388
+84
| +28% | +$10.7K | 0.02% | 460 |
|
|
2023
Q1 | $39.3K | Sell |
304
-45
| -13% | -$5.81K | 0.02% | 523 |
|
|
2022
Q4 | $45.8K | Hold |
349
| – | – | 0.03% | 486 |
|
|
2022
Q3 | $41K | Buy |
349
+40
| +13% | +$4.7K | 0.02% | 503 |
|
|
2022
Q2 | $36K | Hold |
309
| – | – | 0.02% | 483 |
|
|
2022
Q1 | $40K | Sell |
309
-2,351
| -88% | -$304K | 0.02% | 535 |
|
|
2021
Q4 | $406K | Buy |
2,660
+345
| +15% | +$52.7K | 0.19% | 109 |
|
|
2021
Q3 | $374K | Sell |
2,315
-50
| -2% | -$8.08K | 0.23% | 98 |
|
|
2021
Q2 | $387K | Sell |
2,365
-40
| -2% | -$6.55K | 0.24% | 97 |
|
|
2021
Q1 | $362K | Hold |
2,405
| – | – | 0.27% | 89 |
|
|
2020
Q4 | $364K | Sell |
2,405
-337
| -12% | -$51K | 0.3% | 76 |
|
|
2020
Q3 | $371K | Buy |
+2,742
| New | +$371K | 0.37% | 63 |
|